Cancer markers assist in the early diagnosis of this disease and in finding out more about the course of treatment
Cancer Biomarkers are a procedure used to monitor the changes in a person's health as a result of having cancer, in conjunction with other types of tests. Some cancers, such as lung and ovarian cancer, are particularly difficult to monitor because the symptoms are so hard to identify at early stages. They can determine whether cancer has spread beyond the original site of diagnosis and can provide early identification and therapy for this cancer type.
A Cancer Biomarkers refers to an enzyme or substance that is either indicative of cancer in the human body or that shows some level of potential it may develop into cancer. The markers themselves act as sensors that allow medical professionals to locate these molecules and measure them. A cancer biomarker might be a particular response of the body to the existence of cancer or a molecule released by a tumor. Cancer Biomarkers can also be used to study the molecular pathways affected by cancer in humans.
Cancer markers assist in the early diagnosis of this disease and in finding out more about the course of treatment that is required. Many health organizations around the world have started widespread screening for different kinds of diseases. By using new techniques, researchers have been able to demonstrate that even relatively harmless strains of bacteria and viruses can lead to fatal consequences if left unchecked. Cancer Biomarkers and Molecular Medicine have enabled doctors to better identify and monitor very early-stage diseases with greater accuracy and greater efficiency. These services are now widely available.
Some Cancer Biomarkers have proven to be useful in determining whether the disease has spread beyond the original tumor area. Some examples of these include the alkaline phosphatase (ALP), superoxide dismutase (SOD), and glutathione(HIFU). In addition to these two commonly used biomarkers, new compounds such as metronidazole, methotrexate, and cisplatin have shown promise as a new cancer therapy.
See Full Report@ https://www.coherentmarketinsights.com/market-insight/cancer-biomarkers-market-175

Comments
Post a Comment